PBS Biotech
PBS Biotech is produces the easiest to use and most technologically-advanced bioreactors for the pharmaceutical industry.
Launch date
Employees
Market cap
-
Enterprise valuation
$88—132m (Dealroom.co estimates Jan 2023.)
Camarillo California (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
$10.0m | Late VC | ||
* | $22.0m | Late VC | |
Total Funding | $32.0m |
Related Content
Recent News about PBS Biotech
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.